Inqovi is used to treat adult patients with chronic anemia caused by chronic kidney disease (CKD) who are on dialysis. [1]
What is Inqovi's active ingredient?
Inqovi's active ingredient is iron isomaltoside 1000. [1]
How does Inqovi work?
Iron isomaltoside 1000 is an iron replacement product. It replenishes the body's iron stores. Iron is essential for the production of hemoglobin, a protein in red blood cells that carries oxygen. [1]
Are there other iron replacement therapies available?
Yes, several other iron replacement products are available, including intravenous (IV) iron formulations like Venofer (iron sucrose) and Injectafer (ferric carboxymaltose), as well as oral iron supplements. [2][3][4]
What is the typical treatment duration for Inqovi?
The treatment duration with Inqovi depends on the individual patient's iron deficiency and response to therapy. It is administered intravenously. [1]
What are the potential side effects of Inqovi?
Common side effects of Inqovi may include hypersensitivity reactions, dizziness, headache, nausea, vomiting, diarrhea, constipation, abdominal pain, and changes in urine color. Serious side effects can include severe hypersensitivity reactions, including anaphylaxis. [1]
When does the patent for Inqovi expire?
The patent expiration for Inqovi, like other pharmaceuticals, can vary depending on the specific patents filed and their jurisdictions. Information on patent expirations for specific drugs can often be found on specialized databases. [5] For example, DrugPatentWatch.com tracks drug patent information. [5]